Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8445 EUR | +2.18% | +1.20% | -18.09% |
May. 21 | Transcript : Pharming Group N.V. - Shareholder/Analyst Call | |
May. 08 | Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024 |
Sales 2024 * | 266M 289M | Sales 2025 * | 304M 329M | Capitalization | 569M 617M |
---|---|---|---|---|---|
Net income 2024 * | -10M -10.85M | Net income 2025 * | 4M 4.34M | EV / Sales 2024 * | 1.81 x |
Net cash position 2024 * | 87.65M 95.09M | Net cash position 2025 * | 109M 118M | EV / Sales 2025 * | 1.51 x |
P/E ratio 2024 * |
-52.8
x | P/E ratio 2025 * |
-211
x | Employees | 382 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Pharming Group N.V.
1 day | +2.18% | ||
1 week | +1.20% | ||
Current month | -3.65% | ||
1 month | -6.17% | ||
3 months | -19.19% | ||
6 months | -19.88% | ||
Current year | -18.09% |
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Jeroen Wakkerman
DFI | Director of Finance/CFO | 55 | 20-11-15 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 2 M€ | -.--% | ||
0.05% | 7 M€ | -.--% | - | |
0.02% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.8445 | +2.18% | 4,595,581 |
24-05-27 | 0.8265 | -0.66% | 5,121,589 |
24-05-24 | 0.832 | +0.67% | 4,309,913 |
24-05-23 | 0.8265 | -2.02% | 3,479,806 |
24-05-22 | 0.8435 | +3.56% | 5,820,042 |
Real-time Euronext Amsterdam, May 28, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.09% | 604M | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- PHARM Stock